Literature DB >> 3240727

Effect of ketanserin on lipoproteins in patients with essential hypertension.

K Arakawa1, J Sasaki, K Saku, S Ideishi, Y Saeki, K Baba, K Ikeda, Y Kato, H Ohba, H Doi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3240727     DOI： 10.2165/00003495-198800361-00025

Source DB:  PubMed          Journal:  Drugs        ISSN： 0012-6667            Impact factor:   9.546


× No keyword cloud information.
  14 in total

1.  A comprehensive evaluation of the heparin-manganese precipitation procedure for estimating high density lipoprotein cholesterol.

Authors:  G R Warnick; J J Albers
Journal:  J Lipid Res       Date:  1978-01       Impact factor: 5.922

2.  Serum cholesterol during ketanserin and propranolol administration in hypertensive patients.

Authors:  P Lijnen; R Fagard; J Staessen; V Blaton; P Hollez; G Rorive; A Amery
Journal:  J Cardiovasc Pharmacol       Date:  1987-12       Impact factor: 3.105

3.  Effects of treatment on morbidity in hypertension. II. Results in patients with diastolic blood pressure averaging 90 through 114 mm Hg.

Authors: 
Journal:  JAMA       Date:  1970-08-17       Impact factor: 56.272

Review 4.  Antihypertensive treatment and serum lipoproteins.

Authors:  P Weidmann; D E Uehlinger; A Gerber
Journal:  J Hypertens       Date:  1985-08       Impact factor: 4.844

5.  Receptor binding profile of R 41 468, a novel antagonist at 5-HT2 receptors.

Authors:  J E Leysen; F Awouters; L Kennis; P M Laduron; J Vandenberk; P A Janssen
Journal:  Life Sci       Date:  1981-03-02       Impact factor: 5.037

6.  Treatment of hypertension with ketanserin, a new selective 5-HT2 receptor antagonist.

Authors:  G J Wenting; A J Man in 't Veld; A J Woittiez; F Boomsma; M A Schalekamp
Journal:  Br Med J (Clin Res Ed)       Date:  1982-02-20

Review 7.  High density lipoprotein metabolism.

Authors:  S Eisenberg
Journal:  J Lipid Res       Date:  1984-10       Impact factor: 5.922

8.  Characterization of human high-density lipoproteins by gradient gel electrophoresis.

Authors:  P J Blanche; E L Gong; T M Forte; A V Nichols
Journal:  Biochim Biophys Acta       Date:  1981-09-24

9.  [A new determination of the neutral fats in blood serum and tissue. I. Principles, procedure, and discussion of the method].

Authors:  M Eggstein; F H Kreutz
Journal:  Klin Wochenschr       Date:  1966-03-01

10.  Long-term effects on central haemodynamics and body fluid volumes of ketanserin in essential hypertension studies at rest and during dynamic exercise.

Authors:  P Omvik; P Lund-Johansen
Journal:  J Hypertens       Date:  1983-12       Impact factor: 4.844
View more
  1 in total

Review 1.  Ketanserin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in hypertension and peripheral vascular disease.

Authors:  R N Brogden; E M Sorkin
Journal:  Drugs       Date:  1990-12       Impact factor: 9.546
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.